|
Terminated
|
NCT01676766 -
Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease
|
N/A |
|
Enrolling by invitation
|
NCT06048185 -
Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study
|
|
|
Completed
|
NCT03772665 -
Safety and Efficacy of Emixustat in Stargardt Disease
|
Phase 3 |
|
Recruiting
|
NCT04545736 -
Oral Metformin for Treatment of ABCA4 Retinopathy
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT05674058 -
Function and Imaging Assessments for G1961E-associated Stargardt Disease
|
|
|
Completed
|
NCT04909398 -
Pupil Dynamics and Color Vision for the Detection of Eye Diseases
|
N/A |
|
Completed
|
NCT02255981 -
Efficacy of Acupuncture in Macular Diseases
|
N/A |
|
Completed
|
NCT05266014 -
This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT02435940 -
Inherited Retinal Degenerative Disease Registry
|
|
|
Completed
|
NCT05417126 -
Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease
|
Phase 2 |
|
Terminated
|
NCT02875704 -
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
|
|
|
Completed
|
NCT03033108 -
Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
|
Phase 2 |
|
Recruiting
|
NCT03011541 -
Stem Cell Ophthalmology Treatment Study II
|
N/A |
|
Completed
|
NCT02410122 -
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
|
|
|
Enrolling by invitation
|
NCT04239625 -
Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
|
Phase 2 |
|
Recruiting
|
NCT05956626 -
Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT02402660 -
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
|
Phase 2 |
|
Completed
|
NCT01977846 -
A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
|
|
|
Completed
|
NCT05904444 -
The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies
|
N/A |
|
Completed
|
NCT02230228 -
Phase 1 Safety Study of ALK-001 in Healthy Volunteers
|
Phase 1 |